Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?

@article{Kim2011ProstateCM,
  title={Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?},
  author={Michelle Miran Kim and Karen Elizabeth Hoffman and Lawrence B. Levy and Steven J Frank and Thomas J. Pugh and Seungtaek Choi and Quynh Nhu N. Nguyen and Sean E. McGuire and Andrew K. Lee and Deborah Ann Kuban},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2011},
  volume={29 7_suppl},
  pages={181}
}
BACKGROUND A competing risks analysis was undertaken to identify subgroups at greatest risk of dying from prostate cancer (PC) after definitive external beam radiation therapy (RT)±androgen deprivation therapy (ADT) in the prostate specific antigen (PSA) era. METHODS Outcomes of 2675 men with localised PC treated with RT±ADT from 1987-2007 were analysed. Prostate cancer-specific mortality (PCSM) and non-PCSM rates were calculated after stratifying patients according to National Comprehensive… CONTINUE READING